Asensus Surgical (NYSE:ASXC) announced today that a hospital in Japan agreed to lease and utilize its Senhance surgical robot system.
Saiseikai Shiga Hospital in Ritto, Japan, agreed to a deal with Research Triangle Park, North Carolina-based Asensus.
The hospital will use the Asensus Senhance surgical system. The first-of-its-kind digital laparoscopic surgical robot uses augmented intelligence to perform procedures through machine learning. It features surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization.
Asensus said in a news release that Senhance is the first platform to offer 3mm instruments. They are the smallest instrument available in the world on a robotic surgical platform.
“We are very excited to be partnering with Saiseikai Shiga Hospital, one of the leading hospitals in Japan. While the system will be initially utilized in the General Surgery Department, we look forward to assisting the hospital in expanding their Senhance program into additional departments and specializations,” said Anthony Fernando, Asensus Surgical president and CEO. “We continue to drive increased utilization of Senhance globally as surgeons continue to see the value associated with Senhance’s clinical intelligence and digital tools which have wide applicability across surgical specialties and types of procedures.”
Asensus Senhance: powered by augmented reality
Senhance is powered by Asensus’ Intelligent Surgical Unit (ISU). The ISU enables real-time surgical image analytics coupled with machine vision-driven control of the camera. It responds to commands and recognizes certain objects in the surgical field.
The ISU allows a surgeon to measure anatomy, place digital tags and enhance the surgical image. It offers augmented intelligence-drive control of the camera so the surgeon can focus on other critical tasks.
“We are very excited to incorporate the unique features of the Senhance System into our surgical offerings. Familiarity with laparoscopy, lower cost per procedure similar to laparoscopy and clinical intelligence capabilities combined with robotic precision and novel features make the platform a wonderful addition to our hospital,” said Dr. M. Masuyama, VP and head of the surgical department at Saiseikai Shiga Hospital. “As we focus on providing the highest level of care for our patients, the Senhance System will allow us to expand our robotic surgery department to help deliver better patient outcomes.”